As part of its BsUFA II commitments, the FDA updated a 2015 draft guidance for biosimilar sponsors seeking formal meetings with the agency.
Source: Drug Industry Daily
As part of its BsUFA II commitments, the FDA updated a 2015 draft guidance for biosimilar sponsors seeking formal meetings with the agency.
Source: Drug Industry Daily